Title : PSK enhances the efficacy of docetaxel in human gastric cancer cells through inhibition of nuclear factor-kappaB activation and survivin expression.

Pub. Date : 2010 Mar

PMID : 20126979






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PSK enhances the efficacy of docetaxel in human gastric cancer cells through inhibition of nuclear factor-kappaB activation and survivin expression. Docetaxel baculoviral IAP repeat-containing 5 Mus musculus
2 In addition, to elucidate the molecular mechanism, we analyzed the activation of NF-kappaB and the subsequent production of the antiapoptotic molecule survivin in combined treatment with docetaxel and PSK. Docetaxel baculoviral IAP repeat-containing 5 Mus musculus
3 In SCID mouse, PSK significantly inhibited growth of TMK-1 subcutaneous xenografts in combination with low-dose docetaxel, and decreased the docetaxel-induced survivin expression in TMK-1 xenografts. Docetaxel baculoviral IAP repeat-containing 5 Mus musculus
4 Our data suggest that PSK enhanced the efficacy of docetaxel against human gastric cancer both in vitro and in vivo, at least in part, by downregulating NF-kappaB activation and survivin expression induced by low-dose docetaxel. Docetaxel baculoviral IAP repeat-containing 5 Mus musculus
5 Our data suggest that PSK enhanced the efficacy of docetaxel against human gastric cancer both in vitro and in vivo, at least in part, by downregulating NF-kappaB activation and survivin expression induced by low-dose docetaxel. Docetaxel baculoviral IAP repeat-containing 5 Mus musculus